Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment.

Subst Use Misuse. 1998 Dec;33(14):2803-17. Unique Identifier : AIDSLINE MED/99084790
Fugelstad A; Agren G; Romelsjo A; Center for Dependency Disorders of St. Goran's Hospital,; Stockholm, Sweden.


Abstract: This study analyzes the mortality, hospitalizations, and arrests in a cohort of severe intravenous heroin users divided into three groups: those in methadone treatment, those discharged from treatment, and those who never received treatment. The study population consists of 101 heroin users, of whom 56 were HIV-seropositive. Because of intensive drug misuse, they underwent coercive residential treatment in Stockholm during the 3-year period 1986-1988. The mortality was lower in the methadone group, and all seven deaths were related to HIV-infection. Outside the program, 24 of 29 persons died from external violence and poisoning.
Keywords: JOURNAL ARTICLE Adult Cohort Studies Crime/*STATISTICS & NUMER DATA Female Heroin Dependence/PSYCHOLOGY/*THERAPY Hospitalization/*STATISTICS & NUMER DATA Human HIV Infections/*MORTALITY HIV Seropositivity Male Methadone/*THERAPEUTIC USE Narcotics/*THERAPEUTIC USE Substance-Related Disorders/THERAPY Sweden/EPIDEMIOLOGY ViolenceKWDjournalarticleadultcohortstudiescrime/KWDstatistics&numerdatafemaleheroindependence/psychology/KWDtherapyhospitalization/KWDstatistics&numerdatahumanhivinfections/KWDmortalityhivseropositivitymalemethadone/KWDtherapeuticusenarcotics/KWDtherapeuticusesubstance-relateddisorders/therapysweden/epidemiologyviolence
990530
A9950924

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .